Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**KLC2 antisense RNA 2 (KLC2-AS2)** is a natural antisense long non-coding RNA, transcribed from the opposite DNA strand of the KLC2 gene locus[5]. Natural antisense RNAs typically regulate their corresponding sense genes or nearby genomic regions, potentially controlling transcription, mRNA stability, or chromatin accessibility[7]. However, the precise biological role, expression profile, and clinical relevance of KLC2-AS2 remain poorly defined in the current scientific literature[5][7]. There is no evidence that KLC2-AS2 itself encodes a protein or serves as a direct therapeutic target. Notes and caveats: - There are no published studies linking KLC2-AS2 to human diseases or molecular functions beyond its annotation as a natural antisense lncRNA[5][7]. - The gene is distinct from its sense partner, **KLC2**, which is protein-coding and has known disease and molecular roles, including transport in neurons and potential involvement in neurodegeneration and cancer[1][3]. - If you require information for the **KLC2 protein**, that will yield additional disease and functional details, but "KLC2-AS2" specifically refers to the antisense RNA transcript.
None known (no drugs targeting this RNA; mechanisms of lncRNA action generally can include transcriptional interference, chromatin remodeling, or RNA-RNA interactions, but specifics for KLC2-AS2 are not reported)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KLC2 antisense RNA 2 (KLC2-AS2).